Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis

Digestive and Liver Disease

Volumn 45, Issue 1, 2013, Pages 43-49

  Iavarone, Massimo ^a   Manini, Matteo Angelo ^a   Sangiovanni, Angelo ^a   Fraquelli, Mirella ^a   Forzenigo, Laura Virginia ^a   Di Tommaso, Luca ^b   Aghemo, Alessio ^a   Roncalli, Massimo ^b   Ronchi, Guido ^a   Colombo, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Cirrhosis; CT scan; Hepatocellular carcinoma; Liver cell dysplasia; Ultrasound

Indexed keywords

ALPHA FETOPROTEIN; HEAT SHOCK PROTEIN 70;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; FEMALE; FOLLOW UP; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE ENHANCEMENT; IMAGE-GUIDED BIOPSY; INCIDENCE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84871620064     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.08.009     Document Type: Article

References (33)

1. Bosch F.X., Ribes J., Díaz M., et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004, 127:S5-S16.
2. Sangiovanni A., Del Ninno E., Fasani P., et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004, 126:1005-1014.
3. Benvegnù L., Gios M., Boccato S., et al. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 2004, 53:744-749.
4. Papatheodoridis G.V., Lampertico P., Manolakopoulos S., et al. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. Journal of Hepatology 2010, 53:348-356.
5. Bruix J., Sherman M. Practice guidelines. Management of hepatocellular carcinoma. Hepatology 2011, 53:1020-1022.
6. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. Journal of Hepatology 2001, 35:421-430.
7. Arii S., Sata M., Sakamoto M., et al. Management of hepatocellular carcinoma: report of consensus meeting in the 45th annual meeting of the Japan Society of Hepatology (2009). Hepatology Research 2010, 40:667-685.
8. Borzio M., Fargion S., Borzio F., et al. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. Journal of Hepatology 2003, 39:208-214.
9. Fracanzani A.L., Burdick L., Borzio M., et al. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology 2001, 34:1109-1112.
10. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
11. Sangiovanni A., Manini M.A., Iavarone M., et al. The diagnostic and economic impact of contrast imaging technique in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 2010, 59:638-644.
12. Lencioni R., Caramella D., Bartolozzi C., et al. Long-term follow-up study of adenomatous hyperplasia in liver cirrhosis. Italian Journal of Gastroenterology 1994, 26:163-168.
13. Celli N., Gaiani S., Piscaglia F., et al. Characterization of liver lesions by real-time contrast-enhanced ultrasonography. European Journal of Gastroenterology and Hepatology 2007, 19:3-14.
14. Bolondi L., Gaiani S., Celli N., et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005, 42:27-34.
15. Takayasu K., Muramatsu Y., Mizuguchi Y., et al. CT imaging of early hepatocellular carcinoma and the natural outcome of hypoattenuating nodular lesions in chronic liver disease. Oncology 2007, 72(Suppl. 1):83-91.
16. Chung J.J., Yu J.S., Kim J.H., et al. Nonhypervascular hypoattenuating nodules depicted on either portal or equilibrium phase multiphasic CT images in the cirrhotic liver. American Journal of Roentgenology 2008, 191:207-214.
17. Vilana R., Forner A., Bianchi L., et al. Intrahepatic peripheral cholangiocarcinoma in cirrhotic patients may display a vascular pattern similar to hepatocellular carcinoma on contrast enhanced ultrasound. Hepatology 2010, 51:2020-2029.
18. Borzio M., Fornari F., De Sio I., et al. Adherence to AASLD guidelines in the " real world" of HCC in Italy. Preliminary results of a prospective study. Hepatology 2010, 52(Suppl.):1162A.
19. International Working Party Terminology of nodular hepatocellular lesions. Hepatology 1995, 22:983-993.
20. International Consensus Group for Hepatocellular Neoplasia Pathologic diagnosis of early HCC. A report from the international group of hepatocellular neoplasia. Hepatology 2009, 49:658-664.
21. Di Tommaso L., Franchi G., Park Y.N., et al. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 2007, 45:725-734.
22. Terasaki S., Kaneko S., Kobayashi K., et al. Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study. Gastroenterology 1998, 115:1216-1222.
23. Park Y.N., Yang C.P., Fernandez G.J., et al. Neoangiogenesis and sinusoidal " capillarization" in dysplastic nodules of the liver. American Journal of Surgical Pathology 1998, 22:656-662.
24. Roncalli M., Roz E., Coggi G., et al. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 1999, 30:1174-1178.
25. Kobayashi M., Ikeda K., Hosaka T., et al. Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis. Cancer 2006, 106:636-647.
26. Kudo M. Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?. Oncology 2010, 78(Suppl. 1):87-93.
27. Llovet J.M., Chen Y., Wurmbach E., et al. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 2006, 131:1758-1767.
28. Di Tommaso L., Destro A., Seok J.Y., et al. The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. Journal of Hepatology 2009, 50:746-754.
29. Di Tommaso L., Destro A., Fabbris V., et al. Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma. Hepatology 2011, 53:1549-1557.
30. Kojiro M., Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Seminars in Liver Disease 2005, 25:133-142.
31. Tremosini S., Forner A., Boix L., et al. Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma. Gut 2012, [Epub ahead of print].
32. Sherman M., Bruix J., Porayko M., Tran T. Screening for hepatocellular carcinoma: the rationale for the AASLD recommendations. Hepatology 2012, June. for the AASLD Practice Guidelines Committee, [Epub ahead of print]. 10.1002/hep.25869.
33. Hoshida Y., Villanueva A., Kobayashi M., et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. New England Journal of Medicine 2008, 359:1995-2004.